UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis

Respiratory medicine, 2010-07, Vol.104 (7), p.1035-1041

2010

Volltextzugriff (PDF)

Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation

The Journal of heart and lung transplantation, 2010-10, Vol.29 (10), p.1159-1164

2010

Volltextzugriff (PDF)

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis

Respiratory medicine, 2008-09, Vol.102 (9), p.1305-1310

2008

Volltextzugriff (PDF)

Parameters of donor–recipient size mismatch and survival after bilateral lung transplantation

The Journal of heart and lung transplantation, 2012-11, Vol.31 (11), p.1207-1213.e7

2012

Volltextzugriff (PDF)

A Randomized, Placebo-controlled, Double-blinded, Crossover Trial of Pioglitazone for Severe Asthma

Journal of allergy and clinical immunology, 2017-12, Vol.140 (6), p.1716-1718

2017

Volltextzugriff (PDF)

Pulmonary Hypertension due to Lung Disease and/or Hypoxia

Clinics in chest medicine, 2013-12, Vol.34 (4), p.695-705

2013

Volltextzugriff (PDF)

Comparison of wait times and mortality for idiopathic pulmonary fibrosis patients listed for single or bilateral lung transplantation

The Journal of heart and lung transplantation, 2010-10, Vol.29 (10), p.1165-1171

2010

Volltextzugriff (PDF)

Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?

Respiratory medicine, 2017-01, Vol.122, p.S10-S13

2017

Volltextzugriff (PDF)

The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis

Respiratory medicine, 2006-10, Vol.100 (10), p.1734-1741

2006

Volltextzugriff (PDF)

Native Lung Complications in Single-lung Transplant Recipients and the Role of Pneumonectomy

The Journal of heart and lung transplantation, 2009-08, Vol.28 (8), p.851-856

2009

Volltextzugriff (PDF)

Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis

Genomics (San Diego, Calif.), 2010-09, Vol.96 (3), p.134-145

2010

Volltextzugriff (PDF)

Lung Disease–Related Pulmonary Hypertension

Cardiology clinics, 2022-02, Vol.40 (1), p.77-88

2022

Volltextzugriff (PDF)

Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study

The Journal of heart and lung transplantation, 2021-08, Vol.40 (8), p.822-830

2021

Volltextzugriff (PDF)

sGC stimulators: Evidence for riociguat beyond groups 1 and 4 pulmonary hypertension

Respiratory medicine, 2017-01, Vol.122, p.S28-S34

2017

Volltextzugriff (PDF)

Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment

Respiratory medicine, 2019-07, Vol.153, p.44-51

2019

Volltextzugriff (PDF)

Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.547-553

2024

Volltextzugriff (PDF)

Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)

The Journal of heart and lung transplantation, 2021-06, Vol.40 (6), p.488-493

2021

Volltextzugriff (PDF)

Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis

The Journal of heart and lung transplantation, 2018-07, Vol.37 (7), p.925-932

2018

Volltextzugriff (PDF)

Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis

Contemporary clinical trials, 2021-01, Vol.100, p.106227-106227, Article 106227

2021

Volltextzugriff (PDF)

The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosis

Respiratory medicine, 2020-08, Vol.170, p.106068-106068, Article 106068

2020

Volltextzugriff (PDF)

Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis

The American journal of pathology, 2015-04, Vol.185 (4), p.943-957

2015

Volltextzugriff (PDF)

Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury

The Journal of heart and lung transplantation, 2021-11, Vol.40 (11), p.1454-1462

2021

Volltextzugriff (PDF)

Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis

Respiratory medicine, 2015-07, Vol.109 (7), p.914-922

2015

Volltextzugriff (PDF)

Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.563-570

2024

Volltextzugriff (PDF)

Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease

The Journal of heart and lung transplantation, 2024-09, Vol.43 (9), p.1374-1382

2024

Volltextzugriff (PDF)

1 – 25 von 341

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(326)

Publikationsform

Artikel
(341)

Sprache

Englisch
(341)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis

Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis

Parameters of donor–recipient size mismatch and survival after bilateral lung transplantation

A Randomized, Placebo-controlled, Double-blinded, Crossover Trial of Pioglitazone for Severe Asthma

Pulmonary Hypertension due to Lung Disease and/or Hypoxia

Comparison of wait times and mortality for idiopathic pulmonary fibrosis patients listed for single or bilateral lung transplantation

Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?

The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis

Native Lung Complications in Single-lung Transplant Recipients and the Role of Pneumonectomy

Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis

Lung Disease–Related Pulmonary Hypertension

Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study

sGC stimulators: Evidence for riociguat beyond groups 1 and 4 pulmonary hypertension

Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment

Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD

Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)

Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis

Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis

The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosis

Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis

Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury

Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis

Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection

Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease

Aktive Filter

Suchergebnisse filtern